Who owns PREDICTIVE ONCOLOGY?
- Ticker: POAI
- CUSIP Number: 74039m309
Tip: Access positions for across all investors
Analyze quarterly positions in Predictive Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Predictive Oncology stock
Who bought or sold PREDICTIVE ONCOLOGY this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 141k | $463k | 0% | Dec 2023 |
|
Raymond James & Associates | 121k | $308k | 0% | Mar 2024 |
|
RB Capital Management | 21k | $69k | 0% | Dec 2023 |
|
Carnegie Mellon University | 10k | $34k | 100% | Dec 2023 |
|
UBS Group | 2.6k | $8.4k | 4% | Dec 2023 |
|
Advisor Group Holdings | 475.00 | $1.6k | -69% | Dec 2023 |
|
PSI Advisors | 399.00 | $1.0k | 0% | Mar 2024 |
|
Wells Fargo & Company | 31.00 | $101.999300 | -91% | Dec 2023 |
|
Jpmorgan Chase & Co | 6.00 | $19.999800 | 20% | Dec 2023 |
|
Bank of America Corporation | 4.00 | $14.000000 | 100% | Dec 2023 |
|
PFS Partners | 1.00 | $3.000000 | 100% | Mar 2024 |
|
Who sold out of Predictive Oncology?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
American National Bank | Dec 2023 | 15.00 | $49.000500 |
Cornerstone Planning Group | Sep 2023 | 1.00 | $3.000000 |